63
63
Oct 29, 2014
10/14
by
CSPAN3
tv
eye 63
favorite 0
quote 0
dr. volkow? go ahead. >> in addition to the issue of education which is crucial and that overall there is missing education on the screening and proper prescription and management of pain in medical schools and pharmacy schools, there's also what you're mentioning, improving the access and friendliness of the prescription monitoring programs so that physicians when faced with a patient can access that information not just in their states but in other states, and i think the third issue we need to address is the fact that we have also a serious problem of severe pain of -- numbers of people with severe pain and we do not have adequate treatments to address pain for patients. it's another reality we need to face. >> thank you. dr. clark. >> we also have with the advent of the affordable care act, we have an opportunity to offer alternatives to pain medication for the treatment of pain, and i think that's something we should also keep in mind, that historically one of the problems was that there wer
dr. volkow? go ahead. >> in addition to the issue of education which is crucial and that overall there is missing education on the screening and proper prescription and management of pain in medical schools and pharmacy schools, there's also what you're mentioning, improving the access and friendliness of the prescription monitoring programs so that physicians when faced with a patient can access that information not just in their states but in other states, and i think the third issue we...
206
206
Oct 29, 2014
10/14
by
CSPAN3
tv
eye 206
favorite 0
quote 0
dr. volkow? go ahead. >> in addition to the issue of education which is crucial and that overall there is missing education on the screening and proper prescription and management of pain in medical schools and pharmacy schools, there's also what you're mentioning, improving the access and friendliness of the prescription monitoring programs so that physicians when faced with a patient can access that information not just in their states but in other states, and i think the third issue we need to address is the fact that we have also a serious problem of severe pain of -- numbers of people with severe pain and we do not have adequate treatments to address pain for patients. it's another reality we need to face. >> thank you. dr. clark. >> we also have with the advent of the affordable care act, we have an opportunity to offer alternatives to pain medication for the treatment of pain, and i think that's something we should also keep in mind, that historically one of the problems was that there wer
dr. volkow? go ahead. >> in addition to the issue of education which is crucial and that overall there is missing education on the screening and proper prescription and management of pain in medical schools and pharmacy schools, there's also what you're mentioning, improving the access and friendliness of the prescription monitoring programs so that physicians when faced with a patient can access that information not just in their states but in other states, and i think the third issue we...
87
87
Oct 29, 2014
10/14
by
CSPAN3
tv
eye 87
favorite 0
quote 0
dr. volkow, i'm kind of surprised at how remarkable it is that we have so few medications available to treat addiction. i'm concerned that our desire to find treatments that completely eliminate drug use may keep us from finding treatments that will reduce drug use or reduce the harms associated with drug use, harms like incarceration, family instability, difficulty holding a job. what do you think is needed to further the development of treatments that reduce drug use or related harms? >> well, it's unfortunately a paradoxical situation because we have a disease that has a tremendous impact in terms of morbidity and mortality. science has identified several potential targets that if developed could be beneficial for the treatment. we do not have the interest from the pharmaceutical industry in developing medications for a srs series of reasons. one of the recommendations is how to incentivize a pharmaceutical industry in order for them to invest in the development of medications. the targets are there. you have a condition that actually is chronic. so one of the arguments that they would no
dr. volkow, i'm kind of surprised at how remarkable it is that we have so few medications available to treat addiction. i'm concerned that our desire to find treatments that completely eliminate drug use may keep us from finding treatments that will reduce drug use or reduce the harms associated with drug use, harms like incarceration, family instability, difficulty holding a job. what do you think is needed to further the development of treatments that reduce drug use or related harms?...